Regno Unito -
inglese -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alfuzosin 2.5mg tablets
mawdsley-brooks & company ltd - alfuzosin hydrochloride - oral tablet - 2.5mg
Regno Unito -
inglese -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alfuzosin 2.5mg tablets
zentiva pharma uk ltd - alfuzosin hydrochloride - oral tablet - 2.5mg
Regno Unito -
inglese -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alfuzosin 2.5mg tablets
alliance healthcare (distribution) ltd - alfuzosin hydrochloride - oral tablet - 2.5mg
Regno Unito -
inglese -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alfuzosin 2.5mg tablets
phoenix healthcare distribution ltd - alfuzosin hydrochloride - oral tablet - 2.5mg
Regno Unito -
inglese -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alfuzosin 2.5mg tablets
de pharmaceuticals - alfuzosin hydrochloride - oral tablet - 2.5mg
Regno Unito -
inglese -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alfuzosin 2.5mg tablets
sandoz ltd - alfuzosin hydrochloride - oral tablet - 2.5mg
Regno Unito -
inglese -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alfuzosin 2.5mg tablets
waymade healthcare plc - alfuzosin hydrochloride - oral tablet - 2.5mg
Regno Unito -
inglese -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alfuzosin 2.5mg tablets
milpharm ltd - alfuzosin hydrochloride - oral tablet - 2.5mg
Regno Unito -
inglese -
MHRA (Medicines & Healthcare Products Regulatory Agency)
alfuzosin 2.5mg tablets
mawdsley-brooks & company ltd - alfuzosin hydrochloride - oral tablet - 2.5mg
Israele -
inglese -
Ministry of Health
alfuzosin er teva 10 mg
teva israel ltd - alfuzosin hydrochloride - tablets extended release - alfuzosin hydrochloride 10 mg - alfuzosin - treatment of certain functional symptoms of benign prostatic hypertrophy particularly if surgery has to be delayed for some reason. adjuvant treatment to a catheter in acute urinary retention related to benign prostatic hypertrophy.